Encompass Health Q3 2024 Adj EPS $1.03 Beats $0.94 Estimate, Sales $1.35B Beat $1.33B Estimate
Portfolio Pulse from Benzinga Newsdesk
Encompass Health (NYSE:EHC) reported Q3 2024 earnings per share of $1.03, surpassing the analyst estimate of $0.94. The company's sales reached $1.35 billion, exceeding the expected $1.33 billion and marking an 11.93% increase from the previous year.
October 28, 2024 | 8:22 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Encompass Health's Q3 2024 earnings and sales exceeded analyst expectations, with EPS at $1.03 and sales at $1.35 billion, indicating strong financial performance.
The company's earnings per share and sales both exceeded analyst expectations, which is typically a positive indicator for stock performance. The significant year-over-year sales growth further supports a positive outlook.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100